Industry: Medical Devices & Consumables
Published Date: 2024-09-15
Pages: 89 Pages
Report ld: 3322000
Request Sample
Customized Report
Fully MagLev Left Ventricular Assist Device (LVAD) Market Size(US$)

CAGR 2024-2030
12.5%
Market Size,2030
USD 2,206
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 943 million in 2023 and is forecast to a readjusted size of US$ 2206 million by 2030 with a CAGR of 12.5% during the forecast period 2024-2030.
Currently, the global fully magnetic left levitation ventricular assist device (LVAD) market is monopolized by Abbott's HeartMate 3, which has now become the most commonly used left ventricular assist device (LVAD) in the world, with a market share of over 80%.
From the perspective of the global LVAD device market, the main manufacturer in the United States is Abbott, and full magnetic levitation products have become the absolute mainstream. Competition in Europe is more intense, with more products approved earlier, but they are mainly used the second-generation technology (axial pump). The main player is Berlin heart CmbH.
This report aims to provide a comprehensive presentation of the global market for Fully MagLev Left Ventricular Assist Device (LVAD), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fully MagLev Left Ventricular Assist Device (LVAD) by region & country, by Type, and by Application.
The Fully MagLev Left Ventricular Assist Device (LVAD) market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fully MagLev Left Ventricular Assist Device (LVAD).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fully MagLev Left Ventricular Assist Device (LVAD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fully MagLev Left Ventricular Assist Device (LVAD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fully MagLev Left Ventricular Assist Device (LVAD) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Fully MagLev Left Ventricular Assist Device (LVAD) Product Introduction
1.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Market Size Forecast
1.2.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value (2019-2030)
1.2.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume (2019-2030)
1.2.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Price (2019-2030)
1.3 Fully MagLev Left Ventricular Assist Device (LVAD) Market Trends & Drivers
1.3.1 Fully MagLev Left Ventricular Assist Device (LVAD) Industry Trends
1.3.2 Fully MagLev Left Ventricular Assist Device (LVAD) Market Drivers & Opportunity
1.3.3 Fully MagLev Left Ventricular Assist Device (LVAD) Market Challenges
1.3.4 Fully MagLev Left Ventricular Assist Device (LVAD) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Players Revenue Ranking (2023)
2.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Revenue by Company (2019-2024)
2.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Players Sales Volume Ranking (2023)
2.4 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume by Company Players (2019-2024)
2.5 Global Fully MagLev Left Ventricular Assist Device (LVAD) Average Price by Company (2019-2024)
2.6 Key Manufacturers Fully MagLev Left Ventricular Assist Device (LVAD) Manufacturing Base and Headquarters
2.7 Key Manufacturers Fully MagLev Left Ventricular Assist Device (LVAD) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Fully MagLev Left Ventricular Assist Device (LVAD)
2.9 Fully MagLev Left Ventricular Assist Device (LVAD) Market Competitive Analysis
2.9.1 Fully MagLev Left Ventricular Assist Device (LVAD) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Fully MagLev Left Ventricular Assist Device (LVAD) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fully MagLev Left Ventricular Assist Device (LVAD) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Implantable VAD
3.1.2 External VAD
3.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Type
3.2.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, by Type (2019-2030)
3.2.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, by Type (%) (2019-2030)
3.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume by Type
3.3.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume, by Type (2019-2030)
3.3.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume, by Type (%) (2019-2030)
3.4 Global Fully MagLev Left Ventricular Assist Device (LVAD) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Bridge-to-transplant (BTT)
4.1.2 Destination Therapy (DT)
4.1.3 Others
4.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Application
4.2.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, by Application (2019-2030)
4.2.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, by Application (%) (2019-2030)
4.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume by Application
4.3.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume, by Application (2019-2030)
4.3.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume, by Application (%) (2019-2030)
4.4 Global Fully MagLev Left Ventricular Assist Device (LVAD) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Region
5.1.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Region (2019-2024)
5.1.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Region (2025-2030)
5.1.4 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Region (%), (2019-2030)
5.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume by Region
5.2.1 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume by Region (2019-2024)
5.2.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume by Region (2025-2030)
5.2.4 Global Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume by Region (%), (2019-2030)
5.3 Global Fully MagLev Left Ventricular Assist Device (LVAD) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
5.4.2 North America Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
5.5.2 Europe Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
5.6.2 Asia Pacific Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Region (%), 2023 VS 2030
5.7 South America
5.7.1 South America Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
5.7.2 South America Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
5.8.2 Middle East & Africa Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value
6.2.1 Key Countries/Regions Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Fully MagLev Left Ventricular Assist Device (LVAD) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
6.3.2 United States Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
6.4.2 Europe Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
6.5.2 China Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
6.6.2 Japan Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
6.7.2 South Korea Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
6.8.2 Southeast Asia Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value, 2019-2030
6.9.2 India Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Fully MagLev Left Ventricular Assist Device (LVAD) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Fully MagLev Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Abbott Fully MagLev Left Ventricular Assist Device (LVAD) Product Offerings
7.1.5 Abbott Recent Development
7.2 Suzhou Tongxin Medical Devices
7.2.1 Suzhou Tongxin Medical Devices Company Information
7.2.2 Suzhou Tongxin Medical Devices Introduction and Business Overview
7.2.3 Suzhou Tongxin Medical Devices Fully MagLev Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Suzhou Tongxin Medical Devices Fully MagLev Left Ventricular Assist Device (LVAD) Product Offerings
7.2.5 Suzhou Tongxin Medical Devices Recent Development
7.3 Shenzhen Core Medical Technology
7.3.1 Shenzhen Core Medical Technology Company Information
7.3.2 Shenzhen Core Medical Technology Introduction and Business Overview
7.3.3 Shenzhen Core Medical Technology Fully MagLev Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Shenzhen Core Medical Technology Fully MagLev Left Ventricular Assist Device (LVAD) Product Offerings
7.3.5 Shenzhen Core Medical Technology Recent Development
8 Industry Chain Analysis
8.1 Fully MagLev Left Ventricular Assist Device (LVAD) Industrial Chain
8.2 Fully MagLev Left Ventricular Assist Device (LVAD) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Fully MagLev Left Ventricular Assist Device (LVAD) Sales Model
8.5.2 Sales Channel
8.5.3 Fully MagLev Left Ventricular Assist Device (LVAD) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Fully MagLev Left Ventricular Assist Device (LVAD) market is projected to grow from US$ 1210 million in 2025 to US$ 2730 million by 2032, at a CAGR of 12.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 119
USD 4900.00
(Single User License)
The global Fully MagLev Left Ventricular Assist Device (LVAD) market size was US$ 1210 million in 2025 and is forecast to reach a readjusted size of US$ 2730 million by 2032 with a CAGR of 12.5% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 67
USD 4250.00
(Single User License)
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1210 million in 2025 and is projected to reach US$ 2730 million, growing at a CAGR of 12.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 83
USD 3950.00
(Single User License)
The global Fully MagLev Left Ventricular Assist Device (LVAD) market was valued at US$ 1210 million in 2025 and is anticipated to reach US$ 2730 million by 2032, at a CAGR of 12.5% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 104
USD 2900.00
(Single User License)
The global Fully MagLev Left Ventricular Assist Device (LVAD) market is projected to grow from US$ 1088 million in 2024 to US$ 2454 million by 2031, at a CAGR of 12.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 125
USD 4900.00
(Single User License)
The global Fully MagLev Left Ventricular Assist Device (LVAD) market size was US$ 1088 million in 2024 and is forecast to a readjusted size of US$ 2454 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 74
USD 4250.00
(Single User License)
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1088 million in 2024 and is forecast to a readjusted size of US$ 2454 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 88
USD 3950.00
(Single User License)
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was valued at US$ 1088 million in the year 2024 and is projected to reach a revised size of US$ 2454 million by 2031, growing at a CAGR of 12.5% during the forecast period.
Published Date: 2025-03-10
Pages: 76
USD 2900.00
(Single User License)
A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).
Published Date: 2024-09-15
Pages: 80
USD 4350.00
(Single User License)
A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).
Published Date: 2024-09-15
Pages: 69
USD 2900.00
(Single User License)
The global Fully MagLev Left Ventricular Assist Device (LVAD) market is projected to grow from US$ 1210 million in 2025 to US$ 2730 million by 2032, at a CAGR of 12.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 119
The global Fully MagLev Left Ventricular Assist Device (LVAD) market size was US$ 1210 million in 2025 and is forecast to reach a readjusted size of US$ 2730 million by 2032 with a CAGR of 12.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 67
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1210 million in 2025 and is projected to reach US$ 2730 million, growing at a CAGR of 12.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 83
The global Fully MagLev Left Ventricular Assist Device (LVAD) market was valued at US$ 1210 million in 2025 and is anticipated to reach US$ 2730 million by 2032, at a CAGR of 12.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 104
The global Fully MagLev Left Ventricular Assist Device (LVAD) market is projected to grow from US$ 1088 million in 2024 to US$ 2454 million by 2031, at a CAGR of 12.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 125
The global Fully MagLev Left Ventricular Assist Device (LVAD) market size was US$ 1088 million in 2024 and is forecast to a readjusted size of US$ 2454 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 74
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1088 million in 2024 and is forecast to a readjusted size of US$ 2454 million by 2031 with a CAGR of 12.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 88
The global market for Fully MagLev Left Ventricular Assist Device (LVAD) was valued at US$ 1088 million in the year 2024 and is projected to reach a revised size of US$ 2454 million by 2031, growing at a CAGR of 12.5% during the forecast period.
Published: 2025-03-10
Pages: 76
A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).
Published: 2024-09-15
Pages: 80
A left ventricular assist device (LVAD) is a medical device helps heart pump better when patients have heart failure. Some people use this while waiting for a heart transplant. The MagLev (Magnetic Levitation) ventricular assist device (VAD), also known as a magnetic levitation artificial heart, is an advanced medical device used to treat severe heart failure. The magnetic levitation VAD belongs to the third generation of centrifugal pump type VAD, which is divided into fully magnetic levitation and magnetic-fluid hybrid levitation bearing technology. Depending on their location, fully magnetic levitation VADs can generally be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BiVADs).
Published: 2024-09-15
Pages: 69
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now